At any rate, β-cells acutely treated with BTD have a blunted secretory response attributed to the rapid dissipation of the Cl− gradient maintained by NKCC1 (Best 2005), explaining the intermittent hyperglycemia present in patients treated with diuretics (Jackson 2006). The gene discussed is SLC12A2; the disease is Hyperglycemia.